Cargando…
The use of the NIS reporter gene for optimizing oncolytic virotherapy
Introduction: Oncolytic viruses are experimental cancer therapies being translated to the clinic. They are unique in their ability to amplify within the body, therefore requiring careful monitoring of viral replication and biodistribution. Traditional monitoring strategies fail to recapitulate the d...
Autores principales: | Miller, Amber, Russell, Stephen J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732458/ https://www.ncbi.nlm.nih.gov/pubmed/26457362 http://dx.doi.org/10.1517/14712598.2016.1100162 |
Ejemplares similares
-
ONCOLYTIC VIROTHERAPY
por: Russell, Stephen J, et al.
Publicado: (2012) -
Advances in oncolytic virotherapy
por: Russell, Stephen J., et al.
Publicado: (2022) -
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy
por: Concilio, Susanna C., et al.
Publicado: (2021) -
The use of oncolytic virotherapy in the neoadjuvant setting
por: Thomas, Raquela J, et al.
Publicado: (2022) -
Oncolytic Virotherapy in Glioma Tumors
por: Rius-Rocabert, Sergio, et al.
Publicado: (2020)